Skip to main content
Subscribe
  • Sign Up Free
  • Login
  • Subscribe
  • News
    • Current News
    • Providers
    • Insurance
    • Government
    • Finance
    • Technology
    • Safety & Quality
    • Digital Health
    • Transformation
    • ESG
    • People
    • Regional News
    • Digital Edition (Web Version)
    • Patients
    • Operations
    • Care Delivery
    • Payment
    • Midwest
    • Northeast
    • South
    • West
  • Opinion
    • Bold Moves
    • Breaking Bias
    • Commentaries
    • Letters
    • Vital Signs Blog
    • From the Editor
  • Events & Awards
    • Awards
    • Conferences
    • Galas
    • Virtual Briefings
    • Webinars
    • Nominate/Eligibility
    • 100 Most Influential People
    • 50 Most Influential Clinical Executives
    • Best Places to Work in Healthcare
    • Excellence in Governance
    • Health Care Hall of Fame
    • Healthcare Marketing Impact Awards
    • Top 25 Emerging Leaders
    • Top Innovators
    • Diversity in Healthcare
      • - Luminaries
      • - Top 25 Diversity Leaders
      • - Leaders to Watch
    • Women in Healthcare
      • - Luminaries
      • - Top 25 Women Leaders
      • - Women to Watch
    • Digital Health Transformation Summit
    • ESG: The Implementation Imperative Summit
    • Leadership Symposium
    • Social Determinants of Health Symposium
    • Women Leaders in Healthcare Conference
    • Best Places to Work Awards Gala
    • Health Care Hall of Fame Gala
    • Top 25 Diversity Leaders Gala
    • Top 25 Women Leaders Gala
    • - Hospital of the Future
    • - Value Based Care
    • - Hospital at Home
    • - Workplace of the Future
    • - Digital Health
    • - Future of Staffing
    • - Hospital of the Future (Fall)
  • Multimedia
    • Podcast - Beyond the Byline
    • Sponsored Podcast - Healthcare Insider
    • Video Series - The Check Up
    • Sponsored Video Series - One on One
  • Data Center
    • Data Center Home
    • Hospital Financials
    • Staffing & Compensation
    • Quality & Safety
    • Mergers & Acquisitions
    • Data Archive
    • Resource Guide: By the Numbers
    • Surveys
    • Data Points
  • Newsletters
  • MORE+
    • Contact Us
    • Advertise
    • Media Kit
    • Jobs
    • People on the Move
    • Reprints & Licensing
MENU
Breadcrumb
  1. Home
  2. Providers
April 12, 2016 01:00 AM

Blog: Uninformed docs buy into 'breakthrough' hype

Sabriya Rice
  • Tweet
  • Share
  • Share
  • Email
  • More
    Reprints Print

    Physicians may be overly optimistic about the benefits of newly approved drugs, especially when the therapies are labeled as a “breakthrough,” according to a survey of nearly 700 practicing clinicians.

    The doctors tend to overestimate the efficacy of newer therapies and often believe treatments are supported by stronger evidence than they actually are, according to a JAMA study published Tuesday.

    And misconceptions about what constitutes a breakthrough and how the drug approval process works may lead to certain therapies being over-prescribed and patients being let down by the overstated benefits, the authors state.

    The Food and Drug Administration introduced a breakthrough designation for certain therapies in 2012 with the signing of the controversial Safety and Innovation Act (PDF). Drugs can get the label if "preliminary clinical evidence” shows the treatments substantially improved serious or life threatening conditions. The review and development process for those drugs could then be fast-tracked.

    As of April 2016, the FDA has received more than 340 requests for breakthrough designation. Of those, 111 were granted it, 168 were rejected and 47 were withdrawn from consideration, according to approval reports.

    If manufacturers do not conduct adequate post approval studies to prove the benefit, safety and efficacy of the drug, it can be quickly pulled from the market, the act states.

    However, rapid approval has been criticized by patient safety advocates. They warn that real-world negative experiences are collected over years and that therapies might not be recalled until they harm patients. No “magical post-market surveillance system” exists to flag and pull troubling products from the market quickly, critics say.

    A 2015 study found that use of language such as “breakthrough” and “promising” significantly impacted consumers' views about how a drug works.

    In the JAMA study released Tuesday, researchers from the Brigham and Women's Hospital in Boston, the Dartmouth Institute for Health Policy and Clinical Practice in Lebanon, New Hampshire and the American Board of Internal Medicine in Philadelphia, evaluate the impact of the lingo on clinicians.

    It seems to have the same impact as it does on consumers, found the survey of more than 680 internists and specialists.

    When given a hypothetical scenario in which a patient had a serious medical condition and clinicians were given two options, only 6% chose the treatment option with “early promising results.” The other 94% selected the alternative drug described as “breakthrough.” That's an unexpected finding considering that both drugs were actually breakthrough therapies.

    The clinicians were also quizzed on what breakthrough means and about the FDA approval process. Only nine people got all the answers correct and the majority only correctly answered one on a three-question quiz about the type of evidence the FDA requires to approve a drug.

    A second five-question quiz asked about their understanding of the breakthrough designation. About 42% hadn't even heard of the term before taking the survey. Still, 58% were fairly certain that breakthrough drugs represent a major improvement over existing therapies.

    The authors note the potential for inherent bias in the survey and say the results cannot be generalized. Still, the findings suggest “substantial deficits” in knowledge about FDA rapid approval programs, they state.

    Letter
    to the
    Editor

    Send us a letter

    Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.

    Recommended for You
    The Check Up: Bobby Sepucha, Interwell Health
    The Check Up: Bobby Sepucha, Interwell Health
    hospital mergers roundtable
    CEOs sound off on mergers, healthcare disruptors
    Most Popular
    1
    More healthcare organizations at risk of credit default, Moody's says
    2
    Centene fills out senior executive team with new president, COO
    3
    SCAN, CareOregon plan to merge into the HealthRight Group
    4
    Blue Cross Blue Shield of Michigan unveils big push that lets physicians take on risk, reap rewards
    5
    Bright Health weighs reverse stock split as delisting looms
    Sponsored Content
    Modern Healthcare A.M. Newsletter: Sign up to receive a comprehensive weekday morning newsletter designed for busy healthcare executives who need the latest and most important healthcare news and analysis.
    Get Newsletters

    Sign up for enewsletters and alerts to receive breaking news and in-depth coverage of healthcare events and trends, as they happen, right to your inbox.

    Subscribe Today
    MH Magazine Cover

    MH magazine offers content that sheds light on healthcare leaders’ complex choices and touch points—from strategy, governance, leadership development and finance to operations, clinical care, and marketing.

    Subscribe
    Connect with Us
    • LinkedIn
    • Twitter
    • Facebook
    • RSS

    Our Mission

    Modern Healthcare empowers industry leaders to succeed by providing unbiased reporting of the news, insights, analysis and data.

    Contact Us

    (877) 812-1581

    Email us

     

    Resources
    • Contact Us
    • Advertise with Us
    • Ad Choices Ad Choices
    • Sitemap
    Editorial Dept
    • Submission Guidelines
    • Code of Ethics
    • Awards
    • About Us
    Legal
    • Terms and Conditions
    • Privacy Policy
    • Privacy Request
    Modern Healthcare
    Copyright © 1996-2023. Crain Communications, Inc. All Rights Reserved.
    • News
      • Current News
      • Providers
      • Insurance
      • Government
      • Finance
      • Technology
      • Safety & Quality
      • Digital Health
      • Transformation
        • Patients
        • Operations
        • Care Delivery
        • Payment
      • ESG
      • People
      • Regional News
        • Midwest
        • Northeast
        • South
        • West
      • Digital Edition (Web Version)
    • Opinion
      • Bold Moves
      • Breaking Bias
      • Commentaries
      • Letters
      • Vital Signs Blog
      • From the Editor
    • Events & Awards
      • Awards
        • Nominate/Eligibility
        • 100 Most Influential People
        • 50 Most Influential Clinical Executives
        • Best Places to Work in Healthcare
        • Excellence in Governance
        • Health Care Hall of Fame
        • Healthcare Marketing Impact Awards
        • Top 25 Emerging Leaders
        • Top Innovators
        • Diversity in Healthcare
          • - Luminaries
          • - Top 25 Diversity Leaders
          • - Leaders to Watch
        • Women in Healthcare
          • - Luminaries
          • - Top 25 Women Leaders
          • - Women to Watch
      • Conferences
        • Digital Health Transformation Summit
        • ESG: The Implementation Imperative Summit
        • Leadership Symposium
        • Social Determinants of Health Symposium
        • Women Leaders in Healthcare Conference
      • Galas
        • Best Places to Work Awards Gala
        • Health Care Hall of Fame Gala
        • Top 25 Diversity Leaders Gala
        • Top 25 Women Leaders Gala
      • Virtual Briefings
        • - Hospital of the Future
        • - Value Based Care
        • - Hospital at Home
        • - Workplace of the Future
        • - Digital Health
        • - Future of Staffing
        • - Hospital of the Future (Fall)
      • Webinars
    • Multimedia
      • Podcast - Beyond the Byline
      • Sponsored Podcast - Healthcare Insider
      • Video Series - The Check Up
      • Sponsored Video Series - One on One
    • Data Center
      • Data Center Home
      • Hospital Financials
      • Staffing & Compensation
      • Quality & Safety
      • Mergers & Acquisitions
      • Data Archive
      • Resource Guide: By the Numbers
      • Surveys
      • Data Points
    • Newsletters
    • MORE+
      • Contact Us
      • Advertise
      • Media Kit
      • Jobs
      • People on the Move
      • Reprints & Licensing